Abstract Number: 263 • 2014 ACR/ARHP Annual Meeting
Nutraceutical Products and Pain or Non-Pain Medications Use in Patients with Knee Osteoarthritis
Background/Purpose: Knee osteoarthritis (OA) causes substantial health burden and economic costs including medications and neutraceuticals for pain. The aim of this analysis was to describe…Abstract Number: 262 • 2014 ACR/ARHP Annual Meeting
Longitudinal Assessment of Promis Pediatric Item Banks in Children with Chronic Musculoskeletal Pain
Background/Purpose Assessing clinical status in musculoskeletal pain syndromes requires self-report of pain and function. Yet, the field suffers from a lack of psychometrically sound, consistently…Abstract Number: 261 • 2014 ACR/ARHP Annual Meeting
Validation of the Dutch-Flemish Promis Pain Behavior and Pain Interference Item Banks in Patients with Chronic Pain
Background/Purpose: In the assessment of chronic pain patients it is important to measure pain behavior and pain interference. The National Institutes of Health’s Patient-Reported Outcomes…Abstract Number: 260 • 2014 ACR/ARHP Annual Meeting
Validation of the Dutch-Flemish Promis Physical Functioning Item Bank in Patients with Chronic Pain
Background/Purpose: In the assessment of chronic pain patients it is important to measure physical functioning. The National Institutes of Health’s Patient-Reported Outcomes Measurement Information System…Abstract Number: 259 • 2014 ACR/ARHP Annual Meeting
Development of Pediatric Item Banks to Measure Pain Behavior in the Patient Reported Outcomes Measurement Information System
Background/Purpose The NIH Patient Reported Outcomes Measurement Information System (PROMIS) has created publicly available patient reported outcomes measures in several domains of physical, social and…Abstract Number: 277 • 2014 ACR/ARHP Annual Meeting
Nearly 20% of Children ARE NOT Correctly Classified According to Current ILAR Classification in a Printo Dataset of More THAN 12,000 Juvenile Idiopathic Arthritis Patients
Background/Purpose Juvenile idiopathic arthritis (JIA) is an exclusion diagnosis that encompasses all forms of arthritis that begin before the age of 16 years, persist for…Abstract Number: 276 • 2014 ACR/ARHP Annual Meeting
Growth during Tocilizumab Therapy for Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data from a Phase 3 Clinical Trial
Background/Purpose: Elevated interleukin-6 (IL-6) levels have been associated with low growth velocity in patients with juvenile idiopathic arthritis (JIA).1 The efficacy of tocilizumab (TCZ), an…Abstract Number: 267 • 2014 ACR/ARHP Annual Meeting
Selective and Peripheral-Specific Trk Inhibitor Shows Potent Analgesic Effect Comparable to Morphine in Rat Osteoarthritis Model without CNS Toxicity
Background/Purpose Tropomyosin receptor kinase (Trk) receptors are a family of three closely related receptor tyrosine kinases; TrkA, TrkB and TrkC. Especially, the peripheral TrkA in…Abstract Number: 238 • 2014 ACR/ARHP Annual Meeting
RANKL and OPG Gene Polymorphisms: Association with Vertebral Fractures and Bone Mineral Density in Premenopausal Systemic Lupus Erythematosus
Background/Purpose To evaluate single nucleotide polymorphisms (SNPs) of the receptor activator of NF-κB ligand (RANKL), RANK and osteoprotegerin (OPG) genes in premenopausal systemic lupus erythematosus…Abstract Number: 237 • 2014 ACR/ARHP Annual Meeting
Analysis of Vitamin D Receptor Gene Polymorphisms and Bone Mineral Density in a Population of Women with Rheumatoid Arthritis in Use of Steroid
Background/Purpose: To determinate the association between vitamin D receptor (VDR) gene alleles and bone mineral density (BMD), comparing a group of healthy pre-menopausal white women…Abstract Number: 257 • 2014 ACR/ARHP Annual Meeting
Quality of Life Assessment of Adults Patients with X-Linked Hypophosphoremia
Background/Purpose: X-Linked Hypophosphatemia (XLH) is the most common form of heritable rickets. Although disease severity is variable, adults with XLH may suffer from skeletal symptoms…Abstract Number: 256 • 2014 ACR/ARHP Annual Meeting
Characteristics of Pain in Fabry Disease
Background/Purpose Fabry disease (FD) is an X-linked disorder caused by a deficiency of lysosomal alpha-galactosidase A resulting in accumulation of glycosphingolipids. Clinical manifestations include a…Abstract Number: 255 • 2014 ACR/ARHP Annual Meeting
Pain As Predictor of Organ Involvement in Fabry Disease
Background/Purpose Fabry disease (FD) in a X-linked hereditary lysosomal disorder due to alphagalactosidase A deficiency, leading to the accumulation of its substrate (globotriaosylceramide) in vessels,…Abstract Number: 254 • 2014 ACR/ARHP Annual Meeting
The Effect of Milnacipran on Pain in Rheumatoid Arthritis Patients with Widespread Pain: a Randomized Blinded Crossover Trial
Background/Purpose: Clinical trials have shown that serotonin norepinephrine reuptake inhibitors, such as milnacipran, decrease pain in chronic non-inflammatory pain conditions like fibromyalgia and osteoarthritis. We…Abstract Number: 252 • 2014 ACR/ARHP Annual Meeting
Preliminary Validation of the Michigan Body Map
Background/Purpose One of the hallmark features of fibromyalgia and other centralized pain states is widespread body pain. We developed the Michigan Body Map (MBM) to…
ACR Meeting Abstracts